Third Harmonic Bio Form 4: RSUs Settled and Shares Cancelled in Dissolution
Rhea-AI Filing Summary
Christopher M. Murphy, Chief Financial & Business Officer of Third Harmonic Bio, Inc. (THRD), reported on Form 4 that 47,500 restricted stock units vested and were settled on 08/11/2025. The settled shares received a liquidation distribution of $5.35 per share. The filing also states the transaction reflects a cancellation of shares in connection with the dissolution of the issuer. Following the reported transaction, Mr. Murphy beneficially owns 0 shares of common stock according to the Form 4.
Positive
- None.
Negative
- 47,500 restricted stock units were settled and then cancelled in connection with the issuer's dissolution
- Liquidation distribution of $5.35 per share paid on the settled shares
- Reporting person now shows 0 shares of common stock beneficially owned following the transaction
Insights
TL;DR: Form 4 shows settlement of 47,500 RSUs, a $5.35 liquidation distribution per share, and share cancellation tied to issuer dissolution.
The filing documents an insider settlement of restricted stock units on 08/11/2025 that resulted in a liquidation distribution of $5.35 per share and records cancellation of common stock due to the issuer's dissolution. From a governance perspective, the combination of a liquidation payment and explicit cancellation language indicates a wind-down of equity interests rather than an ongoing equity issuance event. The reporting officer now shows zero beneficial ownership post-transaction, which is consistent with share cancellation tied to dissolution proceedings. This is a material corporate action for shareholders because it signals termination of equity stakes.
TL;DR: Insider received liquidation proceeds on vested RSUs; 47,500 shares settled and were cancelled as part of issuer dissolution.
The transaction is recorded as the deemed vesting and settlement of 47,500 restricted stock units, with a per-share liquidation distribution of $5.35. The Form 4 labels the transaction with a cancellation tied to the dissolution of the issuer, and reports zero common shares owned following the transaction. For investors, the direct implication in this filing is the conversion of equity compensation into a cash liquidation payment and the elimination of those shares through cancellation.